EZZ Life Science Holdings Ltd (ASX:EZZ) chairman Glenn Cross joins Proactive’s Jonathan Jackson to discuss a five-year sales agreement with Pinehills (Hong Kong) Limited. Pinehills will purchase EZZ-branded products worth at least A$15 million in the first year, starting May 2024, with a minimum 10% annual increase in purchase volume over the term. The agreement will expand EZZ’s distribution into China, Vietnam and other Southeast Asian markets. Pinehills, established in 2022, specialises in distributing maternal and infant health, skincare and cosmetics products and has a robust distribution network across China and Southeast Asia. Should Pinehills fail to meet the purchase growth requirements, EZZ reserves the right to claim all costs and losses. The agreement concludes on April 30, 2029. Cross highlighted the significance of this agreement in enhancing EZZ’s market reach and customer base, reflecting the company's commitment to growth and innovation.
EZZ Life Science Holdings secures $15 million sales agreement
